Unknown

Dataset Information

0

5:2 intermittent fasting tapers food intake in the refeeding state and ameliorates metabolic disturbances in mice exposed to olanzapine.


ABSTRACT: A considerable number of patients suffer from adverse metabolic reactions caused by atypical antipsychotics (AAPs), however, current management strategies are disappointing to clinicians. Preclinical studies have consistently demonstrated that intermittent fasting (IF) has robust disease-modifying efficacy in animal models in a wide range of pathological conditions, especially obesity and diabetes. However, it is unclear what role IF can play in addressing AAPs-induced metabolic disturbances. In our study, we found that a 5:2 IF regimen significantly ameliorated the metabolic disturbances induced by olanzapine (a drug representative of AAPs) in animal models. Meanwhile, our research suggests that IF altering food intake during the refeeding phase may account for the metabolic benefit. This study provides supporting evidence regarding a potentially cost-effective intervention strategy for AAPs-induced metabolic disturbances.

SUBMITTER: Zhang C 

PROVIDER: S-EPMC9358252 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature

altmetric image

Publications

5:2 intermittent fasting tapers food intake in the refeeding state and ameliorates metabolic disturbances in mice exposed to olanzapine.

Zhang Chengfang C   Li Han H   Yan Yabin Y   Zhang Xiyan X   Tu Zhilan Z  

Frontiers in psychiatry 20220725


A considerable number of patients suffer from adverse metabolic reactions caused by atypical antipsychotics (AAPs), however, current management strategies are disappointing to clinicians. Preclinical studies have consistently demonstrated that intermittent fasting (IF) has robust disease-modifying efficacy in animal models in a wide range of pathological conditions, especially obesity and diabetes. However, it is unclear what role IF can play in addressing AAPs-induced metabolic disturbances. In  ...[more]

Similar Datasets

| S-EPMC9126218 | biostudies-literature
| S-EPMC9252891 | biostudies-literature
2025-01-01 | GSE254021 | GEO
2016-07-10 | GSE73179 | GEO
| S-EPMC9445987 | biostudies-literature
| S-EPMC6168430 | biostudies-literature
| S-EPMC6478744 | biostudies-literature
| S-EPMC11861880 | biostudies-literature
| S-EPMC8229452 | biostudies-literature
| S-EPMC4665779 | biostudies-literature